| Trial Identifier: | D6010C00005 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02511795 |
| Start Date: | August 2015 |
| Primary Completion Date: | April 2019 |
| Study Completion Date: | October 2019 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version | |
| Spanish Translation |
| Country | Location |
|---|---|
| Canada, ON | Toronto, ON, Canada, M5G 2M9 |
| United States of America, CO | Denver, CO, United States of America, 80218 |
| United States of America, FL | Sarasota, FL, United States of America, 34232 |
| United States of America, NY | New York, NY, United States of America, 10033 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
| United States of America, TX | Houston, TX, United States of America, 77030 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company